Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?
AbstractAutoimmune hepatitis (AIH) is characterized by a progressive destruction of the liver parenchyma and a chronic fibrosis. The current treatment of autoimmune hepatitis is still largely dependent on the administration of corticosteroids and cytostatic drugs. For a long time the development of novel therapeutic strategies has been hampered by a lack of understanding the basic immunopathogenic mechanisms of AIH and the absence of valid animal models. However, in the past decade, knowledge from clinical observations in AIH patients and the development of innovative animal models have led to a situation where critical factors driving the disease have been identified and alternative treatments are being evaluated. Here we will review the insight on the immunopathogenesis of AIH as gained from clinical observation and from animal models. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Christen, U.; Hintermann, E. Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models? Int. J. Mol. Sci. 2016, 17, 2007.
Christen U, Hintermann E. Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models? International Journal of Molecular Sciences. 2016; 17(12):2007.Chicago/Turabian Style
Christen, Urs; Hintermann, Edith. 2016. "Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?" Int. J. Mol. Sci. 17, no. 12: 2007.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.